| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 72989* | 2016 |
| Third universal definition of myocardial infarction K Thygesen, JS Alpert, AS Jaffe, ML Simoons, BR Chaitman, HD White circulation 126 (16), 2020-2035, 2012 | 17357* | 2012 |
| ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart … Writing Committee Members, EM Antman, DT Anbe, PW Armstrong, ... Circulation 110 (5), 588-636, 2004 | 9498* | 2004 |
| An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction Gusto Investigators New England Journal of Medicine 329 (10), 673-682, 1993 | 4610 | 1993 |
| Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty Epic Investigators New England Journal of Medicine 330 (14), 956-961, 1994 | 3016 | 1994 |
| Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes JB Green, MA Bethel, PW Armstrong, JB Buse, SS Engel, J Garg, R Josse, ... New England Journal of Medicine 373 (3), 232-242, 2015 | 2929 | 2015 |
| ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article: a report of the American … E Braunwald, EM Antman, JW Beasley, RM Califf, MD Cheitlin, ... Journal of the American College of Cardiology 40 (7), 1366-1374, 2002 | 2614 | 2002 |
| The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction GUSTO Angiographic Investigators New England Journal of Medicine 329 (22), 1615-1622, 1993 | 2132 | 1993 |
| Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure M Packer, PA Poole-Wilson, PW Armstrong, JGF Cleland, JD Horowitz, ... Circulation 100 (23), 2312-2318, 1999 | 1711 | 1999 |
| Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes PURSUIT Trial Investigators New England Journal of Medicine 339 (7), 436-443, 1998 | 1682 | 1998 |
| Cardiac troponin T levels for risk stratification in acute myocardial ischemia EM Ohman, PW Armstrong, RH Christenson, CB Granger, HA Katus, ... New England Journal of Medicine 335 (18), 1333-1342, 1996 | 1497 | 1996 |
| Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials E Boersma, RA Harrington, DJ Moliterno, H White, P Théroux, ... The Lancet 359 (9302), 189-198, 2002 | 1391 | 2002 |
| Effect of nesiritide in patients with acute decompensated heart failure CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ... New England Journal of Medicine 365 (1), 32-43, 2011 | 1372 | 2011 |
| Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure JA Ezekowitz, FA McAlister, PW Armstrong Circulation 107 (2), 223-225, 2003 | 1314 | 2003 |
| Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients E Boersma, KS Pieper, EW Steyerberg, RG Wilcox, WC Chang, KL Lee, ... Circulation 101 (22), 2557-2567, 2000 | 1299 | 2000 |
| Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes SV Rao, JG Jollis, RA Harrington, CB Granger, LK Newby, PW Armstrong, ... Jama 292 (13), 1555-1562, 2004 | 1213 | 2004 |
| Acute coronary care in the elderly, part I: non–ST-segment–elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart … KP Alexander, LK Newby, CP Cannon, PW Armstrong, WB Gibler, ... Circulation 115 (19), 2549-2569, 2007 | 1173* | 2007 |
| Enoxaparin vs unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary … SYNERGY Trial Investigators Jama 292 (1), 45-54, 2004 | 1047 | 2004 |
| Prasugrel versus clopidogrel for acute coronary syndromes without revascularization MT Roe, PW Armstrong, KAA Fox, HD White, D Prabhakaran, ... New England journal of medicine 367 (14), 1297-1309, 2012 | 1044 | 2012 |
| Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction PW Armstrong, AH Gershlick, P Goldstein, R Wilcox, T Danays, Y Lambert, ... New England Journal of Medicine 368 (15), 1379-1387, 2013 | 1033 | 2013 |
